Both in Biotechnology
Tectonic Therapeutic vs X4 Pharmaceuticals
Over the past year TECX returned +21.3% and XFOR returned −18.4%; their daily moves had a correlation of 0.21.
TECX +21.3% XFOR −18.4%Growth of $1, one year, split-adjusted
| Metric | TECX | XFOR |
|---|---|---|
| Price | $20.30 | $3.24 |
| Market cap | $396.9M | $321.2M |
| Today | +6.95% | +2.21% |
| 1 month | −9.4% | +17.0% |
| 6 months | −30.0% | −26.0% |
| Year to date | −2.7% | −19.0% |
| 1 year | +15.9% | −20.8% |
| Revenue growth (YoY) | — | +346.3% |
| Gross margin | — | 81.6% |
| Net margin | — | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 20.3× |
| Net cash | $226.9M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 60.9% |
| Short % of float | 19.1% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).